Recent studies have reported significantly greater risks of developing AD and rates of cognitive decline in female carriers of the APOE ε4 (e.g., Altmann et al., 2014, Kozauer et al., 2008, Lin et al., 2015). The gene discussed is APOE; the disease is Alzheimer disease.